Table 2 Comparison of the studied variables according to gender
From: Non Hodgkin lymphoma in Lebanon: a retrospective epidemiological study between 1984 and 2019
Variable | Male | Female | p | Statistical test used |
|---|---|---|---|---|
Death | Â | Â | 0.108 | Chi-square |
 No | 274 (52.6%) | 247 (47.4%) |  |  |
 Yes | 106 (59.6%) | 72 (40.4%) |  |  |
Cell type NHL | Â | Â | 0.069 | Chi-square |
 B | 320 (53.1%) | 283 (46.9%) |  |  |
 T | 41 (65.1%) | 22 (34.9%) |  |  |
Lesion at diagnosis | Â | Â | 0.188 | Chi-square |
 Nodal | 233 (52.7%) | 209 (47.3%) |  |  |
 Extranodal | 147 (57.9%) | 107 (42.1%) |  |  |
Staging | Â | Â | 0.427 | Chi-square |
 1 | 55 (56.7%) | 42 (43.3%) |  |  |
 2 | 95 (53.1%) | 84 (46.9%) |  |  |
 3 | 98 (58.7%) | 69 (41.3%) |  |  |
 4 | 111 (50.7%) | 108 (49.3%) |  |  |
First line chemotherapy | Â | Â | 0.036 | Chi-square |
 RCHOP | 146 (51.4%) | 138 (48.6%) |  |  |
 Dose dense | 60 (66.7%) | 30 (33.3%) |  |  |
 Other regimens | 96 (57.1%) | 72 (42.9%) |  |  |
Radiotherapy | Â | Â | 0.763 | Chi-square |
 No | 306 (54.4%) | 257 (45.6%) |  |  |
 Yes | 72 (55.8%) | 57 (44.2%) |  |  |
Age (in years) | 53.56 ± 17.95 | 53.48 ± 16.87 | 0.954 | Student t test |